http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-105935444-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-505 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-22 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-395 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P15-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-10 |
| filingDate | 2016-05-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2019-11-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2019-11-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-105935444-B |
| titleOfInvention | Application of the anti-PEDF monoclonal antibody in diabetic men erectile dysfunction disease |
| abstract | The invention belongs to biotech drug applied technical fields, disclose anti-PEDF monoclonal antibody in the application of diabetic men erectile dysfunction disease；Find that anti-PEDF monoclonal antibody can improve diabetic men cavernous body endothelial function and reduction Endothelial apoptosis by research, increase sponge volume density, increase the release of NO in cavernous body, improve diabetes mellitus induced erectile function, application of the anti-PEDF monoclonal antibody in the drug of preparation treatment male erectile dysfunction is provided, which can be used for treating the diseases such as the sex dysfunction as caused by diabetes or/and metabolic syndrome. |
| priorityDate | 2016-05-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 221.